Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial

ConclusionsVitamin D supplementation can decrease circulating 27HC of breast cancer patients, likely by CYP27A1 inhibition. This suggests a new and additional modality by which vitamin D can inhibit ER+ breast cancer growth, though a larger study is needed for verification.

http://link.springer.com/10.1007/s10549-017-4562-4

Source: Breast Cancer Research and Treatment - November 7, 2017 Category: Cancer & Oncology Source Type: research